EFTR
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
EFTR
Delisted
EFTR was delisted on the 2nd of July, 2024.
30 hedge funds and large institutions have $10.4M invested in eFFECTOR Therapeutics, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 1 closing their positions.
Holders
30
Holders Change
+3
Holders Change %
+11.11%
% of All Funds
0.48%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
4
Increased
7
Reduced
3
Closed
1
Calls
$43K
Puts
–
Net Calls
+$43K
Net Calls Change
-$14K
Top Buyers
Top Sellers
1 |
TSS
1
Two Sigma Securities
New York
|
$0 |
2 |
WFAG
2
Wescott Financial Advisory Group
Philadelphia,
Pennsylvania
|
$17.3K |
3 |
3
Two Sigma Investments
New York
|
$16.5K |